To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Stanley Capital to buy Noden from PDL BioPharma
PDL BioPharma Inc has agreed to sell Noden to Stanley Capital for up to $48.25 million in cash.
